S&P7,747.7+1.06%

Nasdaq29,482.3+1.16%Stoxx6,382.6+0.32%FTSE10,831.5+0.70%Nikkei64,769.7+0.86%Hang Seng25,753.6+2.14%DXY99.00−0.00%EUR/USD1.1633+0.41%USD/JPY156.08−1.79%GBP/USD1.3534+0.37%Gold4,518.9+0.61%Silver67.26+0.43%WTI91.89+0.65%Brent95.77+0.26%10Y4.76%−3 bpVIX14.32−5.79%S&P7,747.7+1.06%Nasdaq29,482.3+1.16%Stoxx6,382.6+0.32%FTSE10,831.5+0.70%Nikkei64,769.7+0.86%Hang Seng25,753.6+2.14%DXY99.00−0.00%EUR/USD1.1633+0.41%USD/JPY156.08−1.79%GBP/USD1.3534+0.37%Gold4,518.9+0.61%Silver67.26+0.43%WTI91.89+0.65%Brent95.77+0.26%10Y4.76%−3 bpVIX14.32−5.79%S&P7,747.7+1.06%

SRRK

Five-day −5.6%. Clock PDUFA: Apitegromab BLA — spinal muscular atrophy (2026-10-06). Off the index.

Cheap: Five-day −5.6%
Clock: PDUFA: Apitegromab BLA — spinal muscular atrophy · 6 Oct 2026
Book: target 61.23 · stop 56.18 · R:R 2.12 · 5d -5.6
Knife: The move is already spent — flat after the catalyst, or a date that slipped with nothing new behind it. · 11 Oct 2026